Showing results (31-40 of 2,348) with videos related to
Sort By:
Pageof 235
Gastroenterology|August 1, 1983
Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trialS Meyers, D B Sachar, J D Goldberg, et al.Gut|April 1, 1978
Significance of anergy to dinitrochlorobenzene (DNCB) in inflammatory bowel disease: family and postoperative studiesS Meyers, D B Sachar, R N Taub, et al.Journal of Clinical Gastroenterology|June 1, 1983
Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease?A L Talansky, S Meyers, A J Greenstein, et al.The New England Journal of Medicine|October 2, 1975
Reoperation and recurrence in Crohn's colitis and ileocolitis; Crude and cumulative ratesA J Greenstein, D B Sachar, B S Pasternack, et al.Gastroenterology|September 1, 1980
Toxic megacolon in ulcerative colitis complicated by pneumomediastinum: report of two casesG R Mogan, D B Sachar, J Bauer, et al.Journal of Clinical Gastroenterology|February 1, 1988
The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balanceS Klein, S Meyers, P O'Sullivan, et al.Journal of Clinical Gastroenterology|April 1, 1993
Meta-analysis of the effectiveness of current drug therapy of ulcerative colitisA A Kornbluth, P Salomon, H S Sacks, et al.Gut|July 1, 1984
Loss of suppressor T-cells in active inflammatory bowel diseaseN J Godin, D B Sachar, R Winchester, et al.Gut|February 1, 1988
Fulminant herpes simplex hepatitis in a patient with ulcerative colitisR D Shlien, S Meyers, J A Lee, et al.Journal of Clinical Gastroenterology|October 1, 1988
Fecal alpha 1-antitrypsin as a measure of Crohn's disease activity. The effect of therapy and anatomical extent of diseaseS Meyers, S Lichtiger, E J Feuer, et al.Pageof 235